CLINICAL_TRIALS
trial_result
· 2014-10-27
Clinical Trial Update: Vatalanib in Treating Patients With Recurrent or Progressive Meningioma [Phase 2]
Summary
Phase 2 clinical trial evaluating vatalanib for recurrent or progressive meningioma has completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors, Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-27